Skeletal muscle metabolic health is critical for mobility and an underrecognized target of metabolic acidosis in chronic kidney disease. Impaired muscle mitochondrial metabolism underlies poor physical endurance increasing the risk of mobility disability. The proposed project will use precise in vivo tools to study the pathophysiology of poor physical endurance in a clinical trial treating metabolic acidosis among persons living with chronic kidney disease.
Age range
21 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
muscle mitochondrial oxidative capacity by 31P MRS
Timeframe: 16 weeks
Insulin sensitivity (SI) by insulin clamp
Timeframe: 16 weeks
total work performed on cycle ergometry VO2
Timeframe: 16 weeks
muscle work efficiency cycle ergometry
Timeframe: 16 weeks
Walking endurance by 6-minute walk
Timeframe: 16 weeks
FACIT-F Fatigue (PRO)
Timeframe: 16 weeks